Articles by Sean Milmo - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Sean Milmo

A Lifecycle Approach to Process Validation

A science- and risk-based approach to verify and demonstrate that a process operating within predefined specified parameters consistently produces material that meets all its critical quality attributes.
Jun 1, 2013

A science- and risk-based approach to verify and demonstrate that a process operating within predefined specified parameters consistently produces material that meets all its critical quality attributes.

Should Regulation of Combination Products Become More Centralized in Europe?

While there are those who want combination products to be controlled by a centralized pharmaceutical-type approval system, the majority of the medical technology industry wants to retain a decentralized device-focused approach.
May 1, 2013

While there are those who want combination products to be controlled by a centralized pharmaceutical-type approval system, the majority of the medical technology industry wants to retain a decentralized device-focused approach.

Advancing QbD in the EU

EU authorities are stepping up their efforts to incorporate QbD principles.
Apr 1, 2013

EU authorities are stepping up their efforts to incorporate QbD principles.

Europe and the United States to Negotiate a Free-Trade Agreement

Discussions are underway as the pharmaceutical sector calls for greater consistency in the global monitoring of GMP compliance and quality testing of APIs and finished medicines.
Mar 1, 2013

Discussions are underway as the pharmaceutical sector calls for greater consistency in the global monitoring of GMP compliance and quality testing of APIs and finished medicines.

Falsified Medicines Directive Takes Shape in Europe

The EU fine-tunes the Falsified Medicines Directive.
Jan 1, 2013

The EU fine-tunes the Falsified Medicines Directive.

EU Sets Guidelines for Biosimilar mAbs

The European Medicines Agency has added granularity to its biosimilars approval pathway by releasing a guideline on mAbs.
Nov 1, 2012

The European Medicines Agency has added granularity to its biosimilars approval pathway by releasing a guideline on mAbs.

Report from Turkey

The government of Turkey is drawing up a program in coordination with the pharmaceutical industry to create ways to make the country a regional production center for pharmaceuticals serving Europe, Central Asia, and the Middle East.
Nov 1, 2012

The government of Turkey is drawing up a program in coordination with the pharmaceutical industry to create ways to make the country a regional production center for pharmaceuticals serving Europe, Central Asia, and the Middle East.

ADVERTISEMENT

ADVERTISEMENT

Click here